Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality

Journal article

Peer reviewed

Michael Feher, Mark Joy, Neil Munro, William Hinton, John Williams and Simon de Lusignan

Atherosclerosis, Vol.339, pp.55-56

01/12/2021

PMID: 34802683

Abstract

Cardiac & Cardiovascular Systems

Cardiovascular System & Cardiology

Life Sciences & Biomedicine

Peripheral Vascular Disease

Science & Technology

6 Record Views

Title: Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality
Creators: Michael Feher - University of Oxford
Mark Joy - University of Oxford
Neil Munro - University of Surrey
William Hinton - University of Oxford
John Williams - University of Oxford
Simon de Lusignan - University of Oxford
Publication Details: Atherosclerosis, Vol.339, pp.55-56
Publisher: Elsevier
Number of pages: 2
Date published: 01/12/2021
Identifiers: 99828363302346
Academic Unit: School of Biosciences
Language: English
Resource Type: Journal article